Rockefeller Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,037,763
| Closed | -$19.2M | – | 1616 |
|
|
2023
Q3 | $19.2M | Buy |
1,037,763
+260,361
| +33% | +$4.83M | 0.07% | 270 |
|
|
2023
Q2 | $8.6M | Buy |
777,402
+41,914
| +6% | +$464K | 0.03% | 478 |
|
|
2023
Q1 | $9.88M | Buy |
735,488
+170,303
| +30% | +$2.29M | 0.04% | 408 |
|
|
2022
Q4 | $6.99M | Buy |
565,185
+28,421
| +5% | +$352K | 0.04% | 459 |
|
|
2022
Q3 | $7.49M | Buy |
536,764
+17,042
| +3% | +$238K | 0.04% | 439 |
|
|
2022
Q2 | $7.18M | Buy |
519,722
+30,370
| +6% | +$419K | 0.04% | 430 |
|
|
2022
Q1 | $7.96M | Buy |
489,352
+101,002
| +26% | +$1.64M | 0.04% | 425 |
|
|
2021
Q4 | $6.33M | Buy |
388,350
+51,209
| +15% | +$834K | 0.03% | 477 |
|
|
2021
Q3 | $5.01M | Buy |
337,141
+158,653
| +89% | +$2.36M | 0.03% | 480 |
|
|
2021
Q2 | $3.56M | Buy |
178,488
+178,288
| +89,144% | +$3.56M | 0.02% | 546 |
|
|
2021
Q1 | $4K | Hold |
200
| – | – | ﹤0.01% | 2987 |
|
|
2020
Q4 | $4K | Hold |
200
| – | – | ﹤0.01% | 2525 |
|
|
2020
Q3 | $8K | Hold |
200
| – | – | ﹤0.01% | 2097 |
|
|
2020
Q2 | $10K | Hold |
200
| – | – | ﹤0.01% | 1909 |
|
|
2020
Q1 | $13K | Buy |
+200
| New | +$13K | ﹤0.01% | 1673 |
|